RemSleep Holdings (RMSL) Shares Outstanding (Weighted Average) (2010 - 2026)

RemSleep Holdings (RMSL) reported Shares Outstanding (Weighted Average) of $1.7 billion for Q1 2026, up 10.77% YoY from $1.5 billion in Q1 2025, and up 7.83% on a QoQ basis from $1.6 billion in Q4 2025.

RemSleep Holdings (RMSL) Shares Outstanding (Weighted Average) (2010 - 2026) Analysis & Trends

RemSleep Holdings has disclosed Shares Outstanding (Weighted Average) across 17 years of filings, most recently posting $1.7 billion for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 10.77% year-over-year to $1.7 billion in Q1 2026; TTM through Mar 2026 was $1.7 billion, a 10.77% increase from a year earlier, with the FY2025 full-year figure at $1.6 billion, up 6.18% from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 stood at $1.7 billion, up from $1.6 billion in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $1.7 billion in Q1 2026, with the low at $1.4 billion in Q1 2022.
  • A 5-year average of $1.5 billion and a median of $1.5 billion in 2022 frame the typical range for Shares Outstanding (Weighted Average).
  • The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) jumped 239.92% in 2022, then declined 0.02% in 2023.
  • Year by year, Shares Outstanding (Weighted Average) stood at $1.5 billion in 2022, then decreased by 0.02% to $1.5 billion in 2023, then rose by 1.02% to $1.5 billion in 2024, then gained by 6.18% to $1.6 billion in 2025, then grew by 7.83% to $1.7 billion in 2026.
  • Business Quant data shows RMSL's Shares Outstanding (Weighted Average) at $1.7 billion in Q1 2026, $1.6 billion in Q4 2025, and $1.6 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 1.74 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 382.90 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 1.28 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 1.48 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 579.20 Mn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 456.00 Mn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 385.10 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 98.20 Mn
10 RemSleep Holdings - - - 1.69 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.69 Bn
Dec 31, 2025 1.57 Bn
Sep 30, 2025 1.58 Bn
Jun 30, 2025 1.54 Bn
Mar 31, 2025 1.53 Bn
Dec 31, 2024 1.48 Bn
Sep 30, 2024 1.48 Bn
Jun 30, 2024 1.47 Bn
Mar 31, 2024 1.46 Bn
Dec 31, 2023 1.46 Bn
Sep 30, 2023 1.46 Bn
Jun 30, 2023 1.46 Bn
Mar 31, 2023 1.46 Bn
Dec 31, 2022 1.46 Bn
Sep 30, 2022 1.46 Bn
Jun 30, 2022 1.43 Bn
Mar 31, 2022 1.38 Bn
Dec 31, 2021 700.90 Mn
Sep 30, 2021 691.37 Mn
Jun 30, 2021 469.68 Mn